Lupin Ltd has moved to resolve a key legal overhang in the US, with its wholly owned subsidiary Lupin Pharmaceuticals Inc. (LPI) entering into a settlement agreement in an ongoing antitrust litigation. Background to the caseLPI has been part of multiple civil lawsuits in the US alleging anticompetitive practices linked to certain pharmaceutical products, alongside […]